VEGF angiogenic effects are mediated by three receptor tyrosine kinases (RTKs): VEGFR-1 and VEGFR-2, which play major roles in physiological as well as pathological angiogenesis, including tumor angiogenesis, and VEGFR-3, which can regulate angiogenesis in early embryogenesis but mostly functions as a critical regulator of lymphangiogenesis [85]. Here, KDR is linked to neoplasm.